 |
| |
| |
ECCMID 2024 Wrap Up
Together, we deliver MORE than Results
Because Every Patient Matters |
| |
It was wonderful to connect with so many members of the clinical microbiology and infectious diseases community at ECCMID 2024!
Although ECCMID 2024 has wrapped up, our team remains available to you. We are here to help you and your institution provide a higher level of PCR excellence. |
| |
|
|
|
|
|
| |
|
| Stay Tuned for our 2024 Symposium Recording |
| |
|
Many of you attended our integrated symposium: “Innovating Rapid Molecular Diagnostics for Infectious Diseases: Real World Impact on Patient Care” in Barcelona at ECCMID 2024.
In case you missed it, stay tuned for our up-coming email, where you can watch it again on-demand and access our symposium at your convenience.
|
|
|
|
| |
| |
| |
See you at ESCMID Global 2025!
11 - 15 April 2025, Vienna, Austria
|
|
|
|
| |
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
|
|
 |
About Cepheid
|
| Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform advanced PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. |
| For more information, visit www.cepheid.com. |
|
|
| About Cepheid | Privacy Policy | Contact Us |
Cepheid UK Ltd.
©2024 Cepheid. All Rights Reserved. |
| |
|
|
|
|
|
| |
|
